Pharmacy Practice (PGY 1) – Children’s National Medical Center, Washington, DC
Pediatric Specialty (PGY 2) – Medical University of South Carolina, Charleston, SC
Board Certified Critical Care Pharmacist (BCCCP)Board Certified Pediatric Pharmacy Specialist (BCPPS)
Doctor of Pharmacy – University of Texas at Austin, Austin, TX
Clinical Pharmacy Specialist, Pediatric Critical Care
Residency Preceptor, Pharmacy Residency Program
Sedation
Nutrition Support
Cardiopulmonary resuscitation
O’Neil ER; Schmees LR; Resendiz K et al. Inhaled Tranexamic Acid As a Novel Treatment for Pulmonary Hemorrhage in Critically Ill Pediatric Patients. Crit Care Explor 2020; 2(1):e0075
Resendiz K, Humlicek TJ, Moffett BS. Drugs. In Mery CM (ed), Texas Children’s Hospital Handbook of Congenital Heart Disease (pp.522-534). Houston, TX: Texas Children’s Hospital, 2020.
Moffett BS, Resendiz K, Morris J et al. Population Pharmacokinetics of Vancomycin in the Pediatric Cardiac Surgical Population. J Pediatr Pharmacol Ther. 2019 Mar-Apr; 24(2): 107–116
Resendiz K, Achuff B. Opioid and benzodiazepine bolus use in a pediatric intensive care unit during a city-wide catastrophe. Crit Care Med 2019; 47(1): 665.
Achuff B, Jain P, Resendiz K, et al. Objective sedation in a Pediatric Cardiac Intensive Care Unit decreases narcotic exposure. Crit Care Med 2018; 46(1): 630
Jain P, Achuff BJ, Resendiz K, et al. Do Children with Down syndrome really need higher sedation and analgesia after cardiac surgery? Crit Care Med 2018; 46(1): 98
Resendiz K, Elhoff J, Achuff B, et al. Evaluation of vasopressin effects on ST-segment variability in critically ill pediatric patients. Presented at the Pediatric Cardiac Intensive Care Society’s 13th Annual International Meeting. Washington, DC. December, 2017
American Society of Health-System Pharmacists (ASHP)
Pediatric Cardiac Intensive Care Society (PCICS)
Pediatric Pharmacy Association (PPA); Research Committee
Society of Critical Care Medicine (SCCM); Item Writing Committee